Investor Presentaiton

Executive Committee Jan Fuhr Miller CFO Tenure start 2015 International experience across Canada, France, USA, Sweden and Denmark • Former Vice-President at CMC Biologics, Nordic Finance Leader at Honeywell and Director of Finance & Logistics at Lundbeck • Raymond De Vré CEO Tenure start April 2021 Track record in pharma, most recently as Global Head of Biologics at Dr. Reddy's Laboratories, India; former partner at McKinsey focusing on pharma, biotech, and specialty chemicals companies worldwide CEO since listing on April 29 • Jan Christensen Global Director Sales and Marketing Tenure start 2002 In position since 2010. Previous responsibilities within the Group as Director Sales Europe, Head of Global Generics and Head of Generics Europe Roles as Head of Pharma Nordic at Helm Group, Head of Chemical Department of Statoil Denmark, Sales Manager ICI Nordics and ICI Denmark GLOBAL SUPPORT FOR A QUALITY SOLUTION Daniel Lasanow Director Global Operations Tenure start 2016 • Broad background in production and technical operations within the pharma sector, including multi- • • sites Managing Director at Siegfried and BASF Pharma Production Director at Lonza Belgium and UCB Bioproducts (acquired by Lonza) 19 1999 Christina del Vecchio General Counsel & Corporate Secretary Tenure start September 2021 Previous roles as counsel with NKF, Zurich, and as associate with Latham & Watkins LLP, London Advising international corporate clients on commercial and financing transactions, securities laws, governance, compliance and other legal matters PolyPeptide GROUP

View entire presentation